These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10539872)

  • 61. Value of animal models for Chlamydia pneumoniae-related atherosclerosis.
    Fong IW
    Am Heart J; 1999 Nov; 138(5 Pt 2):S512-3. PubMed ID: 10539861
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions.
    Wissler RW
    Circulation; 1995 Dec; 92(12):3376. PubMed ID: 8521553
    [No Abstract]   [Full Text] [Related]  

  • 63. [Importance of chronic bacterial infections for the onset and development of atherosclerosis].
    Popovic P; Draskovic-Pavlovic B; Dincic D; Obradovic S
    Vojnosanit Pregl; 2001; 58(4):407-13. PubMed ID: 11712222
    [No Abstract]   [Full Text] [Related]  

  • 64. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.
    Hirono S; Pierce GN
    Mol Cell Biochem; 2003 Apr; 246(1-2):91-5. PubMed ID: 12841348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular mediators of arterial inflammation: a role for microbial products?
    Kol A; Libby P
    Am Heart J; 1999 Nov; 138(5 Pt 2):S450-2. PubMed ID: 10539846
    [No Abstract]   [Full Text] [Related]  

  • 68. Chlamydia pneumoniae and atherosclerosis: what we know and what we don't know.
    Hammerschlag MR
    Pediatr Infect Dis J; 2000 Jan; 19(1):75-6. PubMed ID: 10643855
    [No Abstract]   [Full Text] [Related]  

  • 69. [Chlamydia pneumoniae and atherosclerosis].
    Andreasen JJ
    Ugeskr Laeger; 1997 Sep; 159(37):5503-7. PubMed ID: 9312918
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis.
    Ericson K; Saldeen TG; Lindquist O; Pâhlson C; Mehta JL
    Circulation; 2000 Jun; 101(22):2568-71. PubMed ID: 10840006
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    Rev Med Interne; 1996; 17 Suppl 1():45S-47S. PubMed ID: 8760682
    [No Abstract]   [Full Text] [Related]  

  • 72. Mouse models of C. pneumoniae infection and atherosclerosis.
    Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?
    Camm AJ; Fox KM
    Eur Heart J; 2000 Jul; 21(13):1046-51. PubMed ID: 10843822
    [No Abstract]   [Full Text] [Related]  

  • 74. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chlamydia pneumoniae, strain TWAR and atherosclerosis.
    Grayston JT; Kuo CC; Campbell LA; Benditt EP
    Eur Heart J; 1993 Dec; 14 Suppl K():66-71. PubMed ID: 8131792
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential infectious etiologies of atherosclerosis: a multifactorial perspective.
    O'Connor S; Taylor C; Campbell LA; Epstein S; Libby P
    Emerg Infect Dis; 2001; 7(5):780-8. PubMed ID: 11747688
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.
    Ieven MM; Hoymans VY
    J Clin Microbiol; 2005 Jan; 43(1):19-24. PubMed ID: 15634945
    [No Abstract]   [Full Text] [Related]  

  • 78. [Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis].
    Persson K; Boman J
    Lakartidningen; 1998 May; 95(20):2334-6, 2339-40. PubMed ID: 9630800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Collaborative multidisciplinary workshop report: what questions regarding the role of Chlamydia pneumoniae in atherosclerosis and cardiovascular disease need to be addressed utilizing animal models?
    Fong IW; Quinn T; Blessing E; Kuo C; Malinverni R; Lauer M; Mawhorter S; Bachmaier K; Rosenfeld M; Taylor C; Zhong G
    J Infect Dis; 2000 Jun; 181 Suppl 3():S519-20. PubMed ID: 10839751
    [No Abstract]   [Full Text] [Related]  

  • 80. Chlamydia pneumoniae infection and coronary heart disease. Trials should assess whether antibiotics eliminate organism from atherosclerotic lesions.
    Taylor-Robinson D
    BMJ; 1997 Dec; 315(7121):1538. PubMed ID: 9420501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.